Filament Health
Filament Health supports the treatment of mental health conditions through the discovery and delivery of exclusively natural psychedelic medicines.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | CAD1.0m | Post IPO Equity | |
| Total Funding | 000k | ||
| CAD | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 485 % | (71 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (1454 %) | (222 %) | (581 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (4518 %) | (250 %) | (806 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 230 % | 37 % | 84 % |
Source: Company filings or news article
Related Content
Filament Health operates in the burgeoning field of natural psychedelic drug development. The company focuses on extracting, purifying, and standardizing natural compounds from plants that contain psychedelic properties. Filament Health's core business model revolves around leveraging the untapped potential of these natural compounds to create powerful, non-synthetic medicines. The company serves clients in the pharmaceutical and healthcare sectors, aiming to provide innovative treatments for mental health and other conditions. By focusing on natural psychedelics, Filament Health differentiates itself from competitors who rely on synthetic chemicals, offering a unique value proposition. The company generates revenue through the development and licensing of its proprietary extraction and purification technologies, as well as through partnerships and collaborations with research institutions and pharmaceutical companies.
Keywords: natural psychedelics, drug development, plant compounds, extraction, purification, standardization, pharmaceutical, healthcare, mental health, non-synthetic medicines.